BRCA2 rearrangement
|
Ovarian Cancer
|
BRCA2 rearrangement
|
Ovarian Cancer
|
rucaparib Sensitive: C3 – Early Trials
|
rucaparib Sensitive: C3 – Early Trials
|
BRCA2 rearrangement
|
Cholangiocarcinoma
|
BRCA2 rearrangement
|
Cholangiocarcinoma
|
olaparib Sensitive: C4 – Case Studies
|
olaparib Sensitive: C4 – Case Studies
|